Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial Keyvan Karkouti, MD, Christian von Heymann, MD, Christian M. Jespersen, MD, Wolfgang Korte, MD, Jerrold H. Levy, MD, Marco Ranucci, MD, Frank W. Sellke, MD, Howard K. Song, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 4, Pages 927-939 (October 2013) DOI: 10.1016/j.jtcvs.2013.04.044 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Patient disposition. rFXIII, Recombinant factor XIII. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 927-939DOI: (10.1016/j.jtcvs.2013.04.044) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Factor XIII levels. Data shown are means and SDs. rFXIII, Recombinant factor XIII; TDA, trial drug administration. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 927-939DOI: (10.1016/j.jtcvs.2013.04.044) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions